I. B. Hales

A Therapeutic Dilemma: Suppressive Doses of Thyroxine Significantly Reduce Bone Mineral Measurements in Both Premenopausal and Postmenopausal Women with Thyroid Carcinoma

TERRENCEM DIAMOND, Liza Nery, I. B. Hales · The Journal of Clinical Endocrinology & Metabolism · 1991 · 219 citations

Medicine, Endocrinology, Oncology +17

Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.

I. B. Hales, A. McElduff, Patsy Crummer et al. · The Journal of Clinical Endocrinology & Metabolism · 1992 · 139 citations

Medicine, Oncology, Surgery +16

OCULAR CHANGES IN GRAVES' DISEASE<subtitle>A Long-term Follow-up Study</subtitle>

I. B. Hales, FRANCIS F. RUNDLE · QJM · 1960 · 105 citations

Medicine, Ophthalmology, Ocular Disease +12

THE EFFECT OF o,p'‐DDD ON ADRENAL STEROID REPLACEMENT THERAPY REQUIREMENTS

Bruce G. Robinson, I. B. Hales, A.J. Henniker et al. · Clinical Endocrinology · 1987 · 64 citations

Life Sciences, Endocrinology, Pharmacology +15

QUANTITATIVE OBSERVATIONS WITH THE THYROXINE SUPPRESSION TEST OF THYROID FUNCTION*

T. H. ODDIE, FRANCIS F. RUNDLE, I. D. Thomas et al. · The Journal of Clinical Endocrinology & Metabolism · 1960 · 37 citations

Medicine, Endocrinology, Nuclear Medicine +15